ABSTRACT The characterization of the mechanisms that regulate KIT expression in germ cells at different times of their development is important not only in the field of reproduction, but also for a better understanding of the biology of testicular germ cell tumors (TGCTs). Indeed this tyrosine kinase receptor, besides being essential for the survival and proliferation of primordial germ cells (PGCs) and for postnatal spermatogenesis and oogenesis, is also frequently overexpressed or constitutively active due to activating mutations in carcinoma in situ of the testis and in seminomas. In this review, I will summarize available data about the transcriptional mechanisms involved in the control of Kit expression in the germline. Variable mechanisms, involving different germ cell-specific transcription factors, are operating in the various developmental stages: SOX2 and SOHLH1/2 act as direct positive regulators in PGCs and in postnatal spermatogonia, respectively, whereas PLZF suppresses KIT expression in spermatogonial stem cells. DMRT1, acting through indirect mechanisms, suppresses KIT transcription in fetal gonocytes, while activating it in differentiating spermatogonia.
as Bone Morphogenetic Protein 4, stimulate Kit expression in undifferentiated spermatogonia (Pellegrini et al., 2003; Pellegrini et al., 2008; Zhou et al., 2008) . The full-length KIT protein is also expressed in post-natal oocytes, and several reports indicate that it is important for their growth and maturation (Packer et al., 1994; Kissel et al., 2000; Klinger and De Felici, 2002; Hutt et al., 2006) .
On the contrary, with the onset of meiosis Kit expression in male germ cells ceases at both the RNA and protein levels (Sette et al., 2000) . Later on, a truncated Kit product, TR-KIT (an intracellular protein corresponding to the carboxy-terminal portion of the kinase domain), is specifically expressed in post-meiotic stages of spermatogenesis, and is accumulated in mature spermatozoa both in mice and humans (Sorrentino et al., 1991; Rossi et al., 1992; Albanesi et al., 1996; . Sette et al., 1997; Muciaccia et al., 2010) . In human spermatozoa TR-KIT is located in the equatorial region, the area involved in sperm-egg fusion (Muciaccia et al., 2010) . Indeed, TR-KIT is a candidate as one of the sperm-borne factors required for egg activation at fertilization (Sette et al., 1997 (Sette et al., , 1998 (Sette et al., , 2002 .
Thus, due to the important role played by the Kit gene in various stages of gametogenesis, it is of great interest to dissect and characterize the mechanisms that regulate its expression in germ cells at different times of their development.
While it is known that TR-KIT expression in spermatids depends on the activation of a cell and developmental stage-specific promoter within intronic regions of both the mouse and the human Kit gene (Albanesi et al., 1996; Paronetto et al., 2004; Muciaccia et al., 2010) , much less information has been available for long time about the transcriptional mechanisms which control expression of the full-length receptor in mitotic germ cells and in oocytes.
Since KIT is essential not only for germ cells, but also for haematopoietic stem cells (HSC) and melanoblasts, in which its expression is subjected to tight transcriptional control, the details of the mechanisms controlling Kit transcription have been extensively studied in these lineages. In particular, two members of the MYC superfamily of bHLH (Helix-Loop-Helix) transcription factors, TAL1 and MITF, have been shown to regulate Kit expression in early haematopoiesis and in melanogenesis, respectively (Krosl et al., 1998; Isozaki et al., 1994) . In the following paragraphs I will summarize more recent findings that have shed some light on the transcriptional mechanisms involved in the control of Kit expression in the germline, showing that, as expected, these mechanisms differ in the various developmental stages.
Transcriptional elements within the kit gene essential for its expression in the germline Cairns et al., (2003) originally identified the cis-acting elements in the 5' flanking region and the first intron of the Kit gene which are essential for its expression in hematopoietic progenitors and PGCs. They found six DNase I hypersensitive sites (HS1-HS6) within these genomic regions and developed several mouse lines expressing transgenic green fluorescent protein (GFP) under the control of these regulatory elements. A construct driven by the Kit promoter and including all 6 HS sites was found to be highly expressed during mouse development in KIT-expressing cells, including PGCs and hematopoietic progenitors. The Kit promoter alone (comprising only HS1) was found to be sufficient to drive low-level GFP expression in PGCs, but unable to function in hematopoietic cells. Hematopoietic expression further required the addition of the intronic HS2 fragment. This intronic fragment also greatly potentiated expression of the reporter gene in PGCs. Thus, elements within the first intron act as an enhancer in both lineages. Optimal hematopoietic expression further required more downstream elements within the first intron, which were instead not required for expression in PGCs (Cairns et al., 2003) . The mouse transgenic lines obtained with the constructs containing both the Kit promoter region and the first intron were found to express GFP also in postnatal germ cells, while those originating from the construct comprising only the promoter region expressed low levels of EGFP only in PGCs, but not in differentiating spermatogonia (Filipponi et al., 2007) . In the prepuberal testis, the transgenic line expressing EGFP under the control of Kit promoter and first intron showed specific expression only in spermatogonia, and faithfully recapitulated endogenous Kit expression in these cells (Pellegrini et al., 2008) . Indeed, EGFP expression (analogously to endogenous KIT protein), was absent at 1 dpp, appeared at 4 dpp in few small spermatogonial foci within the seminiferous tubules, and was spread at 7 dpp in discrete segments of the testicular tubules, showing the characteristic "wavy" expression pattern of mouse spermatogenesis. Thus, 6.9 kb of the Kit promoter region and 3.5 kb of the first Kit intron contain all the cis-acting elements essential for transcriptional modulation of KIT expression in the germline.
Transcription factors controlling kit expression in the germline
PLZF (promyelocytic leukemia zinc finger, also known as ZFP145, or ZBTB16) is a DNA sequence-specific transcriptional repressor that can exert local and long-range chromatin remodeling activity through the recruitment of DNA histone deacetylases and through the action of several nuclear corepressors (Barna et al., 2002) . PLZF expression has been identified in a particular subset of postnatal male germ cells, the spermatogonial stem cells, and male Plzf knock-out (KO) mice show progressive germ cell depletion due to exhaustion of this cell population, due to the deregulated expression of genes controlling the switch between spermatogonial self-renewal and differentiation (Buaas et al., 2004; Costoya et al., 2004; Payne and Braun, 2006) . Since Kit is a hallmark of differentiating spermatogonia, it was easy to hypothesize that it might be a target of PLZF repression. Indeed, it was found that PLZF directly represses the transcription of Kit (Filipponi et al., 2007) . PLZF represses both endogenous Kit expression and expression of a reporter gene under the control of Kit regulatory elements. A discrete sequence of the Kit promoter, required for PLZF-mediated Kit transcriptional repression, was demonstrated to be bound by PLZF both in vivo and in vitro. Moreover, a 3-bp mutation in this PLZF binding site abolishes the responsiveness of the Kit promoter to PLZF repression. In agreement with these findings, a significant increase in KIT expression was found in the undifferentiated spermatogonia isolated from Plzf KO mice (Filipponi et al., 2007) . Moreover, RA was shown to trigger spermatogonial differentiation through the direct or indirect downregulation of PLZF (Dann et al., 2008) , and up-regulation of KIT (Pellegrini et al., 2008) . Thus, one mechanism by which PLZF maintains the pool of spermatogonial stem cells is actually through a direct repression of Kit transcription. Interestingly, PLZF expression was also found to increase progressively in both male and female mouse fetal germ cells coincidently with down-regulation of KIT expression after 13.5 dpc (Barrios et al., 2012) .
But what are the transcription factors which positively regulate Kit expression in the germline? Good candidates were two bHLH transcription factors specifically expressed in germ cells, SOHLH1 (Spermatogenesis and Oogenesis HLH1) and SOHLH2. Both SOHLHs have been involved in the differentiation of spermatogonia and oocytes (Ballow et al., 2006a; Ballow et al., 2006b; Hao et al., 2008; Pangas et al., 2006; Toyoda et al., 2009; Suzuki et al., 2012) . In the male, deletion of each transcription factor leads to the disappearance of KIT-expressing spermatogonia in the prepuberal testis, whereas, in the female, both SOHLH1 and SOHLH2 ablations are responsible of oocyte loss in the neonatal ovary. An expression study of SOHLH1 and SOHLH2 during fetal and postnatal development. showed a strong positive correlation between KIT and the two transcription factors in postnatal spermatogonia, but not in PGCs (Barrios et al., 2012) . SOHLH2 was found enriched mainly in undifferentiated spermatogonia, whereas SOHLH1 expression was maximal in KIT-dependent stages. Expression of SOHLH1, but not SOHLH2, was increased in postnatal mitotic germ cells by treatment with All-trans Retinoic Acid, a differentiation-inducing analog of RA. Moreover, reporter gene expression driven by sequences contained within the Kit promoter and first intron was strongly up-regulated in transfection experiments overexpressing either SOHLH1 or SOHLH2, and cotransfection of both factors showed a cooperative effect (Barrios et al., 2012) . In vivo, co-immunoprecipitation results evidenced that the two proteins interact and overexpression of both factors increased endogenous KIT expression. In vitro experiments further showed that SOHLH1 and SOHLH2 can independently and cooperatively bind a bHLH binding site containing probe designed on discrete sequences of the Kit transcriptional regulatory regions. Finally, by chromatin immunoprecipitation (ChIP) analysis, SOHLH1 was found to occupy discrete bHLH binding site containing regions within the Kit promoter in spermatogonia chromatin (Barrios et al., 2012; Suzuki et al., 2012) . Moreover, the human SOHLH1 gene, but not a deletion mutant associated to non-obstructive azoospermia, was previously shown to transactivate the human Kit promoter in transfection experiments (Choi et al., 2010) . Interestingly, using conditional gene targeting, it has been shown that loss of the Doublesex-related transcription factor DMRT1 in spermatogonia causes a precocious exit from the spermatogonial program, and that DMRT1 acts in these cells by restricting RA responsiveness, directly repressing transcription of the meiotic inducer STRA8, and activating transcription of SOHLH1, thereby preventing meiosis and promoting spermatogonial development (Matson et al., 2010) . A drastic reduction of KIT expression in spermatogonia was evident in testes from Dmrt1 conditonal KO mice. These data, alltogether, show compelling evidence that SOHLHs directly stimulate Kit transcription in postnatal spermatogonia, thus activating the signalling involved in spermatogonia differentiation and spermatogenetic progression both in mice and in humans. Further experiments are required to show whether SOHLHs are required for Kit expression also in postnatal oocytes.
What about the mechanisms activating Kit transcription in PGCs? As stated above, SOHLHs are not expressed in PGCs at the time that they express Kit (Barrios et al., 2012) . Thus, a different mechanism must be active in the very early stages of gametogenesis to allow the onset of Kit transcription. We recently focused our attention on the possible involvement of the pluripotency-conferring gene Sox2 (SRY-related HMG box 2). Besides being on of the key transcription factors required for embryonic stem cell pluripotency and formation of induced pluripotent stem cells, SOX2 is expressed in mouse PGCs and postnatal oocytes (Avilion et al., 2003; Western et al., 2005 , Campolo et al., 2013 , but the role played by this transcription factor during germ cell development and early embryogenesis was unknown. Since Sox2 ablation causes early embryonic lethality shortly after blastocyst implantation, we generated mice bearing Sox2-conditional deletion in germ cells at different stages of their development through the Cre/loxP recombination system. Embryos lacking Sox2 in PGCs showed a dramatic decrease of germ cell numbers at the time of their specification. At later stages, we found that SOX2 is strictly required for PGC proliferation (Campolo et al., 2013) . We have also found that SOX2 stimulates Kit expression in PGCs and binds to discrete transcriptional regulatory sequences of this gene, which is known to be essential for PGCs survival and proliferation. Interestingly, ChIP analysis showed that these regulatory regions are present within the Kit first intron, which, as stated above, is essential for Kit expression in PGCs. On the contrary Sox2 conditional deletion in meiotic oocytes does not impair postnatal oogenesis and early embryogenesis, indicating that it is not essential for oocyte maturation nor for zygotic development, and inferring that SOX2 is not involved in the regaining of Kit expression during postnatal oogenesis (Campolo et al., 2013) .
These results also imply a strict and intricate relationship between stemness and PGCs identity. The transcriptional network regulating Kit transcription in the mouse germline at different developmental stages is schematically summarized in Fig. 1. Future perspectives: possible applications of studies of kit transcriptional regulation for understanding germ cell cancer
The importance of studies on transcriptional conrol of KIT expression in germ cells is not only limited to the field of gametogenesis, but extends also to that of testicular cancer. Indeed, within testicular germ cell tumors (TGCTs), overexpression of KIT is characteristic of seminomas, whereas most nonseminomas do not express KIT (Strohmeyer et al., 1995; Bokemeyer et al., 1996; Coffey et al., 2008) . In many cases, KIT overexpression in seminoma might be related to an increase in the copy number of the KIT gene, which occurs in 21% of seminomas but only in 9% of nonseminomas (McIntyre et al., 2005) . However, alterations of the transcriptional mechanisms that control KIT expression might occur in other cases. Moreover, somatic activating KIT mutations (mainly substitutions in exon 17 at codon 816) are highly frequent in seminomas (as a review, see Coffey et al., 2008) , implying that pharmacological modulation of mechanisms that regulate germ cell specific KIT expression might have important applications for future therapeutic strategies. This is particularly important, considering that therapies based on direct inhibition of KIT tyrosine kinase activity with imatinib or its derivatives often imply undesired side effects (Gambacorti-Passerini et al., 2003) , and that frequently KIT-activating mutations are resistant to imatinib therapy (Frost et al., 2002) . The importance of studies on the transcriptional network controlling germ cell specific KIT expression can be extended also to other germ cell derived tumors. For instance, it has been proposed that testicular teratoma susceptibility in mice might be linked to the lack of Sox2 repression by DMRT1 in prospermatogonia (Krentz et al., 2009) . Actually this repression might be one of the key mechanisms underlying down-regulation of KIT expression in male mouse fetal gonocytes after germ cell sexual determination. Eventhough SOX2 has been reported not to be expressed in human PGCs (Perrett et al., 2008) , these cells have been found to express SOX17 (De Jong et al., 2008) , which is a srictly related transcription factor showing the same DNA binding properties of SOX2 and interchangeable partner specificity (Jauch et al., 2011) . Moreover, in conflict with previous reports (Korkola et al., 2006; de Jong et al., 2008; Santagata et al., 2007) , SOX2 has been reported to be expressed in human intratubular germ cell carcinoma in situ, the precursor of seminoma (Sonne et al., 2010) , and in other human TGCTs, such as embryonal carcinoma (Western et al., 2005) , and the therapeutic potential of SOX2 inhibition by RNA interference in embryonal carcinoma has been recently proposed (Ushida et al., 2012) .
Clearly, besides transcription, other mechanisms are involved in the regulation of KIT expression in the germline, such as epigenetic events or post-transcriptional control. For instance, it has been reported that all spermatogonia isolated from 8-day-old mice display detectable KIT mRNA, but 30-50% of these lack protein expression (Prabhu et al., 2006) , presumably implying cell specific translational control mechanisms exerted by microRNA and/ or RNA-binding proteins, which are known to play fundamental roles in the regulation of spermatogenesis Messina et al., 2012) . Very recently miRNA 221, which was previously known to target Kit mRNA in hematopoietic stem cells, has been shown to be specifically expressed in spermatogonial stem cells (Smorag et al., 2012) , and evidence has been given that both KIT mRNA and KIT protein abundance are influenced by miRNA 221 and miRNA 222 function in spermatogonia (Yang et al., 2013) . These results imply that, together with repression of Kit transcription exerted by PLZF, microRNAs actually contribute to post-transcriptional silencing of Kit expression in the spermatogonial stem cell pool.
